In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18–Labeled THK5351
JAMA Network Open · 09.05.2024 · 7 (5) · e2410684
DOI: 10.1001/jamanetworkopen.2024.10684 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 09.05.2024. Verfasst von Minah Kim und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Schizophrenia, Astrocytes, Positron-Emission Tomography, Fluorine Radioisotopes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance In vivo imaging studies of reactive astrocytes are crucial for understanding the pathophysiology of schizophrenia because astrocytes play a critical role in glutamate imbalance and neuroinflammation.
Objective
To investigate in vivo reactive astrocytes in patients with schizophrenia associated with positive symptoms using monoamine oxidase B (MAO-B)–binding fluorine 18 ([ 18 F])–labeled THK5351 positron emission tomography (PET). Design, Setting, and Participants In this case-control study, data were collected from October 1, 2021, to January 31, 2023, from the internet advertisement for the healthy control group and from the outpatient clinics of Seoul National University Hospital in Seoul, South Korea, for the schizophrenia group. Participants included patients with schizophrenia and age- and sex-matched healthy control individuals. Main Outcomes and Measures Standardized uptake value ratios (SUVrs) of [ 18 F]THK5351 in the anterior cingulate cortex (ACC) and hippocampus as primary regions of interest (ROIs), with other limbic regions as secondary ROIs, and the correlation between altered SUVrs and Positive and Negative Syndrome Scale (PANSS) positive symptom scores.
Results
A total of 68 participants (mean [SD] age, 32.0 [7.0] years; 41 men [60.3%]) included 33 patients with schizophrenia (mean [SD] age, 32.3 [6.3] years; 22 men [66.7%]) and 35 healthy controls (mean [SD] age, 31.8 [7.6] years; 19 men [54.3%]) who underwent [ 18 F]THK5351 PET scanning. Patients with schizophrenia showed significantly higher SUVrs in the bilateral ACC (left, F = 5.767 [false discovery rate (FDR)–corrected P = .04]; right, F = 5.977 [FDR-corrected P = .04]) and left hippocampus ( F = 4.834 [FDR-corrected P = .04]) than healthy controls. Trend-level group differences between the groups in the SUVrs were found in the secondary ROIs (eg, right parahippocampal gyrus, F = 3.387 [ P = .07]). There were positive correlations between the SUVrs in the bilateral ACC and the PANSS positive symptom scores (left, r = 0.423 [FDR-corrected P = .03]; right, r = 0.406 [FDR-corrected P = .03]) in patients with schizophrenia. Conclusions and Relevance This case-control study provides novel in vivo imaging evidence of reactive astrocyte involvement in the pathophysiology of schizophrenia. Reactive astrocytes in the ACC may be a future target for the treatment of symptoms of schizophrenia, especially positive symptoms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuropsychiatry, Seoul National University Hospital, Seoul, Republic of Korea.
- Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea.
- Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Public Health Medical Services, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
Zitieren
APA
Kim, M., Choi, W., Choi, S., Oh, H., Kim, J., Lee, J., An, S. J., Hwang, J. S., Lee, Y. S., Song, I. C., Moon, S. Y., Lho, S. K., Cho, S. S., & Kwon, J. S. (2024). In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18–Labeled THK5351. JAMA Network Open, 7(5), e2410684. https://doi.org/10.1001/jamanetworkopen.2024.10684
Vancouver
Kim M, Choi W, Choi S, Oh H, Kim J, Lee J, et al. In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18–Labeled THK5351. JAMA Network Open. 2024;7(5):e2410684. doi:10.1001/jamanetworkopen.2024.10684
BibTeX
@article{Kim2024,
author = {Kim, Minah and Choi, Woori and Choi, Sunah and Oh, Harin and Kim, Jongrak and Lee, Jungha and An, Su-Jin and Hwang, Jun Seo and Lee, Yun-Sang and Song, In Chan and Moon, Sun-Young and Lho, Silvia Kyungjin and Cho, Sang Soo and Kwon, Jun Soo},
title = {In Vivo Reactive Astrocyte Imaging in Patients With Schizophrenia Using Fluorine 18–Labeled THK5351},
journal = {JAMA Network Open},
year = {2024},
volume = {7},
number = {5},
pages = {e2410684},
doi = {10.1001/jamanetworkopen.2024.10684}
}
EUVIMED